Spots Global Cancer Trial Database for Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy
Official Title: An Observational Study to Collect and Assess Tissue Samples From Subjects With One of Three Neoplastic Conditions (ANSWer)
Study ID: NCT04014764
Interventions
Study Description
Brief Summary: This is a prospective, multicenter observational study to collect clinically annotated biospecimens in order to assess the correlation between ex vivo data generated by the Notable assay platform and clinical outcome.
Detailed Description: This is a prospective, multicenter, observational study with collection of de-identified biospecimens with matched clinical data from up to 1000 participants from clinical networks in the United States and Canada. Clinical information, demographics, and medical data relevant to cancer status are collected from all participants and their medical record at baseline (at study entry and time of baseline biospecimen collection), and subsequent visits per patient consent, for up to 1 year. The primary assessment is the establishment of a tumor registry with annotated clinical outcomes. Exploratory assessments include correlation of ex vivo functional testing results with clinical outcomes, as well as identification of potential biomarkers that correlate responses with genotype and/or phenotype.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CBCC Global Research, Bakersfield, California, United States
Pacific Central Coast Health Centers -- SLO Oncology and Hematology Health Center, San Luis Obispo, California, United States
Colorado West Healthcare System, dba Grand Valley Oncology, Grand Junction, Colorado, United States
Ocala Oncology Center, Ocala, Florida, United States
Mid Florida Hematology and Oncology Center, Orange City, Florida, United States
Touro Infirmary, New Orleans, Louisiana, United States
Northern Light Cancer Care Center, Brewer, Maine, United States
New York Cancer and Blood Specialists, Port Jefferson Station, New York, United States
East Carolina University, Greenville, North Carolina, United States
The Lindner Center for Research and Education at The Christ Hospital -- The Cancer Center, Cincinnati, Ohio, United States
Utah Cancer Specialists, Salt Lake City, Utah, United States
University Hospital of Alexandroupolis, Alexandroupolis, , Greece
National Kapodistrian University of Athens, Athens, , Greece
Attikon University Hospital, Athens, , Greece
National Kapodistrian Hospital/Laikon General Hospital, Athens, , Greece
University Hospital of Ioánnina, Ioánnina, , Greece
University Hospital Patras, Patras, , Greece
Hospital General Universitario de Alicante, Alicante, , Spain
Hospital San Pedro de Alcántare, Cáceres, , Spain
Hospital Universitari I Politècnic La Fe, Valencia, , Spain
Contact Details
Name: Hiroomi Tada, MD, Ph.D.
Affiliation: Notable Labs
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
